Evidence map›Paper›PMID 37407712›Full record

ArticleSurgical endoscopy2023

Ligamentum teres cardiopexy for post vertical sleeve gastrectomy gastroesophageal reflux.

Emily E Mackey, Fiona J Dore, John F Kelly, Allison S Crawford, Philip Cohen, Donald Czerniach, Richard Perugini, John J Kelly, Nicole B Cherng

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Emily E MackeyDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Fiona J DoreDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
John F KellyDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Allison S CrawfordDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Philip CohenDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Donald CzerniachDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Richard PeruginiDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
John J KellyDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Nicole B CherngDepartment of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, USA. nicole.cherng@umassmemorial.org.ORCID 0009-0005-7547-3210
University of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeVertical sleeve gastrectomy (VSG) evolved in the early 2000s into the standalone weight loss procedure we see today. While numerous studies highlight VSG's durability for weight loss, and improvements co-morbidities such as type 2 diabetes mellitus and cardiovascular disease, patients with gastroesophageal reflux disease (GERD) have been counseled against VSG due to the concern for worsening reflux symptoms. When considering anti-reflux procedures, VSG patients are unable to undergo traditional fundoplication due to lack of gastric cardia redundancy. Magnetic sphincter augmentation lacks long-term safety data and endoscopic approaches have undetermined longitudinal benefits. Until recently, the only option for patients with a history of VSG with medically refractory GERD has been conversion to roux en Y gastric bypass (RNYGB), however, this poses other risks including marginal ulcers, internal hernias, hypoglycemia, dumping syndrome, and nutritional deficiencies. Given the risks associated with conversion to RNYGB, we have adopted the ligamentum teres cardiopexy as an option for patients with intractable GERD following VSG.

methodsA retrospective chart review was conducted of patients who had prior laparoscopic or robotic VSG and subsequently GERD symptoms refectory to pharmacological management who underwent ligamentum teres cardiopexy between 2017 and 2022. Pre-operative GERD disease burden, intraoperative cardiopexy characteristics, post-operative GERD symptomatology and changes in H2 blocker or PPI requirements were reviewed.

resultsOf the study's 60 patients the median age was 50 years old, and 86% were female. All patients had a diagnosis of GERD through pre-operative assessments and were taking antisecretory medication. Of the 36 patients who have completed their one year follow up, 81% of patients had either a decrease in dosage or cessation of the antisecretory medication at one year following ligamentum teres cardiopexy.

conclusionLigamentum teres cardiopexy is a viable alternative to RNYGB in patients with a prior vertical sleeve gastrectomy with medical refractory GERD.

Indexed as

Diabetes Mellitus, Type 2Gastric BypassGastroesophageal RefluxLaparoscopyObesity, MorbidRound LigamentsFemaleGastrectomyHumansMaleMiddle AgedRetrospective StudiesWeight LossCardiopexyGERDLigamentum teresSleeve gastrectomy

Identifiers

PMID37407712
OpenAlexW4383265354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.